Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novolyze is a food safety and quality technology company that provides innovative solutions for the food and pharmaceutical industries. The company specializes in the development of surrogate microorganisms that mimic the behavior of pathogens like Salmonella and Listeria, allowing manufacturers to validate their decontamination processes safely in-plant. Additionally, Novolyze offers a cloud-based software platform that digitizes food safety and quality data, providing real-time monitoring and predictive analytics to optimize production processes. By combining microbiology with digital technology, Novolyze helps companies ensure regulatory compliance, reduce waste, and enhance consumer safety. Their solutions are used by global food leaders to transition from traditional, reactive safety measures to proactive, data-driven quality control.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novolyze.